In conclusion, our results suggest that sequential NIPPV + IMT treatment alleviated dyspnea and improved exercise tolerance and quality of life in COPD patients, which might be related to reduced levels of oxidative stress mediated by SOCS5/JAK2/STAT3 signaling pathway. This evidence concerns the gene STAT3 and chronic obstructive pulmonary disease.